44th EDRN Steering Committee Meeting, 2025
 
The Early Detection Research Network (EDRN) will host its 44th EDRN Steering Committee Meeting from Wednesday-Friday, September 17-19, 2025 at the Fred Hutchinson Cancer Center campus in Seattle, Washington. This meeting is in-person only.
 
 
Meeting Registration, Hotel Rooms:
  • Meeting Registration: Registration is mandatory to attend this event. Fill out this registration form at https://forms.office.com/r/t11VtEmYWa?origin=lprLink to register easily online. Please be complete and accurate when completing this form—especially your email address. The deadline to register is Monday, September 8, 2025.
  • Meeting Location: Fred Hutchinson Cancer Center, 1100 Fairview Avenue N., Seattle, WA 98109.
  • Hotel Rooms: EDRN has a block of sleeping rooms at the The Silver Cloud Hotel The Silver Cloud Hotel which is walking distance to the Fred Hutchinson Cancer Center. The rate for all attendees:
    • $229/night plus taxes (includes breakfast) for non-lake view
    • $249/night plus taxes (includes breakfast) for lake view or a suite.
    • The deadline to book your room is August 26, 2025 or until the room block is full.
    • Complete booking online: https://lakeunion.silvercloud.com/irmng/#/search?g=FHMTGCB&o=LAKEUNION25
    • To book by phone dial 206-447-9500--use code FHMTGCB for the room block.
  • Presentations: All presentations must be sent to the DMCC either by email (if under 24MB) at edrndmcc@fredhutch.org or via OneDrive the day before the scheduled presentation. Presenters will be emailed after they have been granted access to the One Drive folder where presentations can be uploaded. Please use the latest version of PowerPoint. NCI requires that we collect all presentations from EDRN events.


Schedule of Events
(Times of Events are Subject to Change)
  • Tuesday, September 16, 2025: AHEAD Steering Committee Meeting (AHEAD Members Only) 2:00 p.m. to 6:00 p.m.
  • Wednesday-Thursday September 17-18, 2025: Main EDRN Steering Committee Meeting 7:00 a.m. to 6:00 p.m.
  • Wednesday, September 17, 2025: EDRN Collaborative Group Meetings 9:00 a.m. to 1:00 p.m.
  • Thursday, September 18, 2025: EDRN Executive Committee Meeting (Committee Members Only) 12:00 p.m. to 2:00 p.m.
  • Friday, September 19, 2025: Main EDRN Steering Committee Meeting 7:00 a.m. to 10:30 a.m.
Current Agendas Below

Tuesday September 16, 2025: AHEAD Meeting (Closed Meeting - AHEAD Members Only)
2:00pm 6:00pm Eastlake Building/E1-101 AHEAD See separate agenda
 
Day 1: Wednesday September 17, 2025 Main EDRN Steering Committee Meeting
Start End Building/Room Title / Topic Presenter / Institution Number
7:00am 8:00am Weintraub/ Lobby Registration N/A N/A
8:00am 8:15am Weintraub/Pelton Welcome / Fred Hutch Representative Garnet Anderson, PhD, Senior Vice President and Director, Public Health Sciences 01
8:15am 8:45am Weintraub/Pelton State of the EDRN: 25th Anniversary Sudhir Srivastava, PhD, MPH, Senior Scientific Officer & Chief, Cancer Biomarkers Research Group, NCI 02
8:45am 9:00am Transition to Collaborative Group Locations
9:00am 1:00pm See Below Collaborative Group Meetings See separate agendas N/A
    Yale/J2-515 • BGYN Collaborative Group See separate agenda N/A
    Eastlake E3-160 • GI Collaborative Group See separate agenda N/A
    Eastlake E1-101 • GU Collaborative Group See separate agenda N/A
    Weintraub/ Pelton • Lung/AHEAD Collaborative Group See separate agenda N/A
1:00pm 2:30pm On Own Lunch & Networking N/A N/A
2:30pm 6:00pm Weintraub/ Pelton CVC Session 1 Presentations – include BCC and Industry partners N/A
2:30pm 2:50pm
Q&A (5m)
Weintraub/ Pelton CVC Breast Group 1
  • Chris Li, MD, PhD, Fred Hutchinson Cancer Center
  • Savannah Partridge PhD, University of Washington
03
2:50pm 3:10pm
Q&A (5m)
Weintraub/ Pelton EDRN Clinical Validation Center on Pancreatic Cancer
Gulf Coast-Great Lakes-East Coast (GCGLEC) CVC (U01CA200468)
  • Anirban Maitra, MBBS, New York University Langone Health
04
3:10pm 3:30pm
Q&A (5m)
Weintraub/ Pelton CVC Pancreas Group 2
  • Randall Brand, MD, University of Pittsburgh
  • Surinder Batra, PhD, University of Nebraska Medical Center
05
3:30pm 3:50pm
Q&A (5m)
Weintraub/ Pelton CVC Esophagus Group 1: Biomarker Based Interception of Esophageal Adenocarcinoma
  • Sanford Markowitz, MD, PhD, Case Western Reserve University
  • Chetan Bettegowda, MD, PhD, Johns Hopkins University
  • Amitabh Chak, MD, UH Cleveland Medical Center
  • Nicholas Shaheen, MD, MPH, BA, University of North Carolina
  • Sachin Wani, MD, University of Colorado Anschutz Medical Campus
  • Joseph Willis, MD, Case Western Reserve University
06
3:50pm 4:05pm   Break    
4:05pm 4:25pm
Q&A (5m)
Weintraub/ Pelton CVC Head and Neck Group 1
  • Karen Anderson, MD, PhD, Arizona State University
  • Erich Sturgis, MD, MPH, Baylor College of Medicine
07
4:25pm 4:45pm
Q&A (5m)
Weintraub/ Pelton CVC Breast and Lung Imaging Group 1
  • John Heine, PhD, H. Lee Moffitt Cancer Center & Research Institute Inc.
  • Matthew Schabath, PhD, H. Lee Moffitt Cancer Center & Research Institute Inc.
08
4:45pm 5:00pm   Break    
5:00pm 5:20pm
Q&A (5m)
Weintraub/ Pelton CVC Lung Group 1
  • Eric Grogan, MD, Vanderbilt-Ingram Cancer Center
  • Stephen Deppen, PhD, Vanderbilt University Medical Center
09
5:20pm 5:40pm
Q&A (5m)
Weintraub/ Pelton CVC Lung Group 2
  • Samir Hanash, MD, PhD, The University of Texas MD Anderson Cancer Center
10
5:40pm 6:00pm
Q&A (5m)
Weintraub/ Pelton CVC Lung Group 3
  • Victor Velculescu, MD, PhD, Johns Hopkins University
  • David Sidransky, MD, Johns Hopkins University
11
6:00pm 6:00pm Weintraub/ Pelton Adjourn
Day 2: Thursday September 18, 2025 Main EDRN Steering Committee Meeting
Start End Building/Room Title / Topic Presenter / Institution Number
7:00am 8:00am Weintraub/ Lobby Registration N/A N/A
8:00am 8:25am
Q&A (5m)
Weintraub/ Pelton Keynote Speaker 1 Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality from Colorectal Cancer
A Pragmatic, Randomized, Comparative-Effectiveness Study
  • Jason Dominitz, MD, Executive Director, US Department of Veterans Affairs National Gastroenterology & Hepatology Program and Professor of Medicine, Gastroenterology Division, University of Washington
12
8:25am 8:50am
Q&A (5m)
Weintraub/ Pelton Keynote Speaker 2
  • Carolyn Rutter, PhD, Professor, Biostatistics Program & Hutchinson Institute for Outcomes Research (HICOR), Public Health Sciences Division, Fred Hutchinson Cancer Center
13
8:50am 9:10am
Q&A (5m)
Weintraub/ Pelton Summary of the Workshop & Discussion
  • James Willey MD, University of Toledo
  • Cecilia Yeung MD, Fred Hutchinson Cancer Center
14
9:10am 9:30am
Q&A (5m)
Weintraub/ Pelton Move AHEAD for the Earliest Detection of Oral Cancer
  • Yu Leo Lei, PhD, DDS, The University of Texas MD Anderson Cancer Center
15
9:30am 9:50am
Q&A (5m)
Weintraub/ Pelton Breast and Gynecological Cancers CG Summary
  • Savannah Partridge, PhD, University of Washington
  • Abhijit Patel, MD, Yale University
16
9:50am 10:05am   Break    
10:05am 10:25am
Q&A (5m)
Weintraub/ Pelton Lung Cancer CG Summary
  • Eric Grogan, MD, Vanderbilt-Ingram Cancer Center
  • Sara Pai, MD, PhD, Yale University
17
10:25am 10:45am
Q&A (5m)
Weintraub/ Pelton Prostate and Urologic Cancers CG Summary
  • Jeffrey Tosoian, MD, Vanderbilt University Medical Center
  • John Semmes, PhD, Eastern Virginia Medical School
18
10:45am 11:05am
Q&A (5m)
Weintraub/ Pelton GI Collaborative Group
  • Bob Bresalier, MD, The University of Texas MD Anderson Cancer Center
19
11:05am 11:35am
Q&A (5m)
Weintraub/ Pelton General Remarks and Open Discussion with EDRN Steering Committee Members
  • Arul Chinnaiyan, MD, PhD, University of Michigan
  • Karen Anderson, MD, PhD, Arizona State University
N/A
11:35am 12:00pm Undedicated Time
12:00pm 2:00pm On Own Lunch
12:00pm 2:00pm Arnold/E3-160 Executive Committee / NCT (virtual component) – Arul Chinnaiyan on EDRN accomplishments – 10 min + 5 min Questions and Discussion; CG/AHEAD highlights-7 min each followed by 5 min Questions and Discussion, 45 min Open Discussion with NCT members
  • Closed Session
  • EDRN Chair: Overview, State, and Future of EDRN (10 min/5 min Q&A)
  • CG Presentations to the NCT (7 min/5 min Q&A)
  • Accomplishments and Future Plans
  • Discussion (45 min)
N/A
2:00pm 2:20pm
Q&A (5m)
Weintraub/ Pelton CVC Prostate Group 1
  • Martin Sanda, MD, Emory University
20
2:20pm 2:40pm
Q&A (5m)
Weintraub/ Pelton CVC Ovary Group 1
  • Robert Bast, MD, The University of Texas MD Anderson Cancer Center
21
2:40pm 3:00pm
Q&A (5m)
Weintraub/ Pelton Great Lakes-New England (GLNE) Clinical Validation Center Update
  • Bob Bresalier, MD, The University of Texas MD Anderson Cancer Center
  • Sapna Syngal, MD, Dana Farber Cancer Institute
22
3:00pm 3:20pm
Q&A (5m)
Weintraub/ Pelton CVC Colon Group 2
  • Robert Schoen, MD, PhD, University of Pittsburgh Cancer Institute
  • Cristian Tomasetti, PhD, City of Hope/TGen
23
3:20pm 3:35pm   Break    
3:35pm 3:55pm
Q&A (5m)
Weintraub/ Pelton Liver Clinical Validation Center
  • Neehar Parikh, MD, University of Michigan
  • Fasiha Kanwal, MD, Baylor College of Medicine
  • Jorge Marrero, MD, MS, University of Pennsylvania
24
3:55pm 5:15pm Weintraub/ Pelton Clinical Utility Trial & Validation Study Updates N/A
3:55pm 4:25pm
Q&A (5m)
Weintraub/ Pelton National Liver Cancer Screening (TRACER) Trial
  • Neehar Parikh, MD, University of Michigan
25
4:25pm 4:50pm
Q&A (5m)
Weintraub/ Pelton NCI EARLY DETECTION RESEARCH NETWORK PROSTATE MRI BIOMARKER STUDY AND REFERENCE SET (PMRI): PHASE 2
  • John T. Wei, MD, MS, University of Michigan
26
4:50pm 5:15pm
Q&A (5m)
Weintraub/ Pelton APaCC
  • Eugene Koay, MD, PhD, The University of Texas MD Anderson Cancer Center
27
5:15pm 5:40pm
Q&A (5m)
Weintraub/ Pelton Informatics
  • Dan Crichton, MS, NASA Jet Propulsion Laboratory
28
5:40pm 6:00pm
Q&A (5m)
Weintraub/ Pelton NCI’s Early Detection Research Network Clinical Biospecimen Reference Sets - Resource for Community
  • Indu Kohaar, PhD, National Cancer Institute
29
6:00pm 6:00pm Weintraub/ Pelton ADJOURN
Day 3: Friday September 19, 2025 Main EDRN Steering Committee Meeting
Start End Building/Room Title / Topic Presenter / Institution Number
7:00am 8:00am Arnold/Behnke M1-A303/305/307 Registration N/A N/A
8:00am 9:00am Arnold/Behnke M1-A303/305/307 Open Discussion – Team Projects across EDRN to form the basis for potential proposals to CSRN for an ancillary study Karen Anderson, MD, PhD, Arizona State University N/A
9:00am 9:45am Arnold/Behnke M1-A303/305/307 Updates from EDRN Investigators on Markers Reaching Phase 2 and 3 N/A N/A
9:45am 10:30am Arnold/Behnke M1-A303/305/307 Moving Forward with Phase 3 Biomarkers: Intended Goals and Plans N/A N/A
10:30am 10:30am Arnold/Behnke M1-A303/305/307 ADJOURN Steering Committee Meeting N/A N/A
11:00am 1:00pm Eastlake/E1-101 EDRN EC/NCI/CSRN (Closed Session) See separate agenda N/A


If you have any questions regarding meeting registration, please contact EDRN DMCC at edrndmcc@fredhutch.org.

 
 
The meeting registration form created by EDRN DMCC at Fred Hutchinson Cancer Center ©